KRAS and neoplasm: Analysis of PD-L1 protein expression revealed that a greater proportion of tumours with PD-L1 expression on ≥50% of tumuor cells showed double-mutated KRAS/TP53 compared to tumours with low and without PD-L1 expression (25% compared to 17 and 10%).